Poland · Delayed Price · Currency is PLN InventionMed Statistics
Total Valuation
InventionMed has a market cap or net worth of PLN 21.50 million. The enterprise value is 24.27 million.
| Market Cap | 21.50M |
| Enterprise Value | 24.27M |
Important Dates
The next confirmed earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
InventionMed has 202.79 million shares outstanding.
| Current Share Class | 201.79M |
| Shares Outstanding | 202.79M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.61% |
| Owned by Institutions (%) | n/a |
| Float | 113.77M |
Valuation Ratios
The trailing PE ratio is 36.30.
| PE Ratio | 36.30 |
| Forward PE | n/a |
| PS Ratio | 5.74 |
| PB Ratio | 46.29 |
| P/TBV Ratio | 50.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 40.97 |
| EV / Sales | 6.48 |
| EV / EBITDA | 7.97 |
| EV / EBIT | 11.30 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.22, with a Debt / Equity ratio of 6.07.
| Current Ratio | 0.22 |
| Quick Ratio | 0.22 |
| Debt / Equity | 6.07 |
| Debt / EBITDA | 0.93 |
| Debt / FCF | -3.99 |
| Interest Coverage | 1.39 |
Financial Efficiency
Return on equity (ROE) is 91.83% and return on invested capital (ROIC) is 65.24%.
| Return on Equity (ROE) | 91.83% |
| Return on Assets (ROA) | 3.46% |
| Return on Invested Capital (ROIC) | 65.24% |
| Return on Capital Employed (ROCE) | 8.51% |
| Weighted Average Cost of Capital (WACC) | 10.59% |
| Revenue Per Employee | 935,732 |
| Profits Per Employee | 148,081 |
| Employee Count | 4 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.71% in the last 52 weeks. The beta is 0.37, so InventionMed's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -39.71% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.12 |
| Relative Strength Index (RSI) | 43.56 |
| Average Volume (20 Days) | 116,999 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, InventionMed had revenue of PLN 3.74 million and earned 592,324 in profits. Earnings per share was 0.00.
| Revenue | 3.74M |
| Gross Profit | 3.60M |
| Operating Income | 2.15M |
| Pretax Income | 592,324 |
| Net Income | 592,324 |
| EBITDA | 3.04M |
| EBIT | 2.15M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 46,884 in cash and 2.82 million in debt, with a net cash position of -2.77 million or -0.01 per share.
| Cash & Cash Equivalents | 46,884 |
| Total Debt | 2.82M |
| Net Cash | -2.77M |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | 464,414 |
| Book Value Per Share | 0.00 |
| Working Capital | -11.28M |
Cash Flow
In the last 12 months, operating cash flow was -318,113 and capital expenditures -387,814, giving a free cash flow of -705,927.
| Operating Cash Flow | -318,113 |
| Capital Expenditures | -387,814 |
| Depreciation & Amortization | 896,993 |
| Net Borrowing | 736,447 |
| Free Cash Flow | -705,927 |
| FCF Per Share | -0.00 |
Margins
Gross margin is 96.17%, with operating and profit margins of 57.36% and 15.83%.
| Gross Margin | 96.17% |
| Operating Margin | 57.36% |
| Pretax Margin | 15.83% |
| Profit Margin | 15.83% |
| EBITDA Margin | 81.33% |
| EBIT Margin | 57.36% |
| FCF Margin | n/a |
Dividends & Yields
InventionMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 2.76% |
| FCF Yield | -3.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 6, 2022. It was a forward split with a ratio of 4.
| Last Split Date | Sep 6, 2022 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
InventionMed has an Altman Z-Score of -0.8 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.8 |
| Piotroski F-Score | 5 |